Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria De Santis

Showing results (141-150 of 278) with videos related to

Pageof 28
Sort By:
Seminars in Arthritis and Rheumatism|August 13, 2013
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progressionMaurizio Pieroni, Maria De Santis, Gaetano Zizzo, et al.
Swiss Medical Weekly|June 15, 2010
Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effortRichard Cathomas, Daniel Helbling, Frank Stenner, et al.
Journal of Geriatric Oncology|February 15, 2020
Management of bladder cancer in older patients: Position paper of a SIOG Task ForceNicolas Mottet, Maria J Ribal, Helen Boyle, et al.
Rheumatology (Oxford, England)|November 18, 2020
A case of psoriatic arthritis triggered by SARS-CoV-2 infectionLucia Novelli, Francesca Motta, Angela Ceribelli, et al.
International Journal of Environmental Research and Public Health|August 26, 2022
The Preventive Role of Physical Activity in Systemic Sclerosis: A Cross-Sectional Study on the Correlation with Clinical Parameters and Disease ProgressionCristina Antinozzi, Elisa Grazioli, Maria De Santis, et al.
Wiener Klinische Wochenschrift|July 21, 2012
[Therapy of castration-resistant prostate cancer]Michael Rauchenwald, Thomas Bauernhofer, Maria De Santis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983Ronald de Wit, Iwona Skoneczna, Gedske Daugaard, et al.
International Journal of Cardiology|November 24, 2019
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general populationCarlo Selmi, Maria De Santis, Pier Maria Battezzati, et al.
Vaccines|March 26, 2022
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care ProfessionalsElena Azzolini, Lorenzo Maria Canziani, Antonio Voza, et al.
Seminars in Arthritis and Rheumatism|January 18, 2025
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based studyGiacomo De Luca, Maria De Santis, Veronica Batani, et al.
Pageof 28

Showing results (141-150 of 278) with videos related to

Sort By:
Pageof 28
Seminars in Arthritis and Rheumatism|August 13, 2013
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progressionMaurizio Pieroni, Maria De Santis, Gaetano Zizzo, et al.
Swiss Medical Weekly|June 15, 2010
Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effortRichard Cathomas, Daniel Helbling, Frank Stenner, et al.
Journal of Geriatric Oncology|February 15, 2020
Management of bladder cancer in older patients: Position paper of a SIOG Task ForceNicolas Mottet, Maria J Ribal, Helen Boyle, et al.
Rheumatology (Oxford, England)|November 18, 2020
A case of psoriatic arthritis triggered by SARS-CoV-2 infectionLucia Novelli, Francesca Motta, Angela Ceribelli, et al.
International Journal of Environmental Research and Public Health|August 26, 2022
The Preventive Role of Physical Activity in Systemic Sclerosis: A Cross-Sectional Study on the Correlation with Clinical Parameters and Disease ProgressionCristina Antinozzi, Elisa Grazioli, Maria De Santis, et al.
Wiener Klinische Wochenschrift|July 21, 2012
[Therapy of castration-resistant prostate cancer]Michael Rauchenwald, Thomas Bauernhofer, Maria De Santis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983Ronald de Wit, Iwona Skoneczna, Gedske Daugaard, et al.
International Journal of Cardiology|November 24, 2019
Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general populationCarlo Selmi, Maria De Santis, Pier Maria Battezzati, et al.
Vaccines|March 26, 2022
Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care ProfessionalsElena Azzolini, Lorenzo Maria Canziani, Antonio Voza, et al.
Seminars in Arthritis and Rheumatism|January 18, 2025
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based studyGiacomo De Luca, Maria De Santis, Veronica Batani, et al.
Pageof 28